Mouriaux F, Casagrande F, Pillaire M J, Manenti S, Malecaze F, Darbon J M
Institut National de la Santé et de la Recherche Médicale, Contrat Jeune Formation 95-10 (Institut Fédératif de Recherche 30), Toulouse, France.
Invest Ophthalmol Vis Sci. 1998 May;39(6):876-84.
To investigate the levels of the different regulatory proteins involved in the G1 progression and G1/S transition in normal and transformed human choroidal melanocytes (CM).
Three choroidal melanoma cell lines and three CM cultures were used. The purity of the CM cultures was assessed by different approaches, including morphologic study, specific immunostaining, cell proliferation behavior, and transforming growth factor-beta1 responsiveness. The cell cycle protein levels were evaluated by specific immunoblotting of total extracts obtained from the different cell lines.
Alterations were observed in the expression of cylins D1 and E in the transformed cells, whereas the amounts of the cyclin-dependent kinases (CDKs) CDK2 and CDK4 were almost identical in both cell types. Although the expression of cyclin H was slightly increased in transformed cells, neither the CDK7 level nor the CDK7 and cyclin H localizations were altered when compared with those in normal CM. The results suggest the absence of the CDK inhibitor (CKI) p21 in two of the three melanoma cell lines and, as a main feature, a striking underexpression of p27 in the three transformed cell lines. Finally, although the p16 level was almost the same in normal and transformed cells, a loss of p16-CDK4 interaction was observed in two of the three melanoma cell lines.
Deregulated expression of G1 cyclins and CKIs and alteration in the interaction of CKIs with CDKs may be implicated in the neoplastic transformation of human ocular melanocytes to malignant melanoma cells.
研究正常和转化的人脉络膜黑色素细胞(CM)中参与G1期进程和G1/S期转换的不同调节蛋白的水平。
使用三种脉络膜黑色素瘤细胞系和三种CM培养物。通过不同方法评估CM培养物的纯度,包括形态学研究、特异性免疫染色、细胞增殖行为和转化生长因子-β1反应性。通过对从不同细胞系获得的总提取物进行特异性免疫印迹来评估细胞周期蛋白水平。
在转化细胞中观察到细胞周期蛋白D1和E表达的改变,而细胞周期蛋白依赖性激酶(CDK)CDK2和CDK4的量在两种细胞类型中几乎相同。尽管细胞周期蛋白H在转化细胞中的表达略有增加,但与正常CM相比,CDK7水平以及CDK7和细胞周期蛋白H的定位均未改变。结果表明,在三种黑色素瘤细胞系中的两种中不存在CDK抑制剂(CKI)p21,并且作为主要特征,在三种转化细胞系中p27明显低表达。最后,尽管正常细胞和转化细胞中的p16水平几乎相同,但在三种黑色素瘤细胞系中的两种中观察到p16-CDK4相互作用丧失。
G1期细胞周期蛋白和CKI的表达失调以及CKI与CDK相互作用的改变可能与人类眼黑色素细胞向恶性黑色素瘤细胞的肿瘤转化有关。